2 FTSE 100 dividend stocks that I think will pay you for life

These FTSE 100 dividend stocks are only just getting started writes Rupert Hargreaves.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

The FTSE 100 is full of high-quality dividend stocks, but one company that stands out to me right now is the pharma group Hikma Pharmaceuticals (LSE: HIK).

Booming market

Hikma sells branded and non-branded pharmaceutical products into the world’s ever-growing healthcare market.

Inflation Is Coming

Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!

Click here to claim your copy now!

The group’s generics business is its second-biggest division with sales of $690m to $720m expected this year. Its biggest division is Hikma’s own-brand injectables, which is projected to yield revenues in the $870m to $900m range for 2019.

Over the past six years, the firm’s top line has grown at a compound annual rate of nearly 9% as the company has benefited from the booming demand for pharmaceutical products around the world, and the launch of its own new treatments.

Going forward, I expect this trend to continue. Management has been focusing on building out the company’s injectables business for the past few years, where profit margins are roughly double those booked in the generics division.

For example, in the first half of 2019, Hikma launched 37 new products across all markets and increased R&D investment by around $10m to $72m for the first six months of 2019 as part of management’s goal to “build our pipeline of higher-value and complex products.

Future growth

Hikma is investing for the future, and this investment should translate into top and bottom-line growth in the years ahead. It is also good news for dividend hunters.

Over the past seven years, as the company’s net profit has jumped from $212m to $353m (projected for 2019), Hikma’s dividend per share has doubled.

Analysts are expecting further growth in the years ahead, as the payout is covered three times by earnings per share, which leaves plenty of room for additional dividend growth and investment in the business at the same time.

While the stock might not offer the highest dividend yield around (it currently stands at 1.8%) the stock’s track record of dividend growth makes this a dividend champion in my eyes.

Rapid growth

I believe that health care provider NMC Health (LSE: NMC) has the same attractive qualities as Hikma.

Demand for healthcare around the world is only growing, and NMC operates in some of the world’s most affluent and fastest-growing economies. Its primary market is the United Arab Emirates, but the company has expanded into Oman and Saudi Arabia in recent years.

And if the group’s growth over the past five years is anything to go by, these growth initiatives should lead to a surge in earnings for NMC over the next decade.

Since 2013, the company’s net profit has grown at a compound annual rate of 30%. Meanwhile, its annual dividend to investors has grown as a compound annual rate of 33%.

As NMC continues to rack up earnings growth in the 25%+ per annum range, I expect the stock’s dividend growth to continue as it has done since 2013.

Right now, the shares support a dividend yield of 0.6%, but this is expected to hit 1% for 2019, and 1.1% for 2020. Dividend cover stands at 5.5 times, which suggests to me that when the firm decides to slow its expansion plans, it could potentially double or triple shareholder payouts. That’s why I think NMC could pay you for the rest of your life.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Rupert Hargreaves owns no share mentioned. The Motley Fool UK owns shares of and has recommended NMC Health. The Motley Fool UK has recommended Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Should you invest the value of your investment may rise or fall and your Capital is at Risk. Before investing your individual circumstances should be considered, so you should consider taking independent financial advice.

More on Investing Articles

Smiling senior white man talking through telephone while using laptop at desk.
Investing Articles

£10,000 invested in BT shares 10 years ago is now worth this much

It's painful to remember that BT shares reached over £10 at the peak of the dot com bubble in 1999.…

Read more »

Close-up Of A Piggybank With Eyeglasses And Calculator On Desk
Investing Articles

Is now the time to buy bank shares?

Our writer considers whether bank shares could be a bargain buy for his portfolio right now -- or a potential…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

After steep falls, are Royal Mail shares a steal?

Royal Mail shares have more than halved since peaking a year ago. After months of steep falls, this popular stock…

Read more »

Young Woman Drives Car With Dog in Back Seat
Investing Articles

Dirt-cheap, 1 of my best stocks to buy also pays an above-average dividend!

This Fool has decided to buy the shares on his best stocks to buy now list with the shares looking…

Read more »

Light bulb with growing tree.
Investing Articles

The AFC share price just tanked! Is now the time to buy?

The AFC share price fell nearly 10% on Wednesday after the H1 revenue announcement. So, should I add this stock…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

These shares have been growing dividends for decades. I’d buy!

Our writer considers the merits for his portfolio of buying two shares with a track record of growing dividends.

Read more »

Close-up of British bank notes
Investing Articles

Is the M&G dividend yield heading to 10%?

As the M&G dividend yield heads towards double digits, out writer explains why he is considering buying more of the…

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

3 top dividend shares to buy now

With weakness in the markets, I reckon it's a good time to search for top dividend shares to buy now.

Read more »